REUTERS - Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR & Co LP to acquire Capsugel, a U.S. maker of capsule products and ...

(Reuters) — Lonza Group AG announced its biggest ever acquisition on Thursday with a deal to buy Capsugel, a U.S. maker of capsule products and other drug delivery systems, for $5.5 billion in cash to ...

Swiss pharmaceutical manufacturer Lonza Group AG is in advanced talks to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems, for more than $5 billion, according to ...

Switzerland-based CDMO Lonza said it has been given the green light by regulators for its $5.5 billion deal to buy U.S.-based contract capsule and drug producer Capsugel from KKR. The company said it ...

Three days after acknowledging it was interested in buying Capsugel, Swiss CDMO Lonza pulled the trigger on a $5.5 billion deal to acquire the U.S.-based contract capsule and drug producer and create ...

Lonza Group, a Swiss chemicals and biotechnology company, will acquire Capsugel for $5.5 billion, reports Reuters. Here are four things to know about the deal. 1. Capsugel, based in Morristown, N.J., ...

The Swiss pharmaceutical services firm Lonza has agreed to acquire Capsugel, a specialist in oral drug delivery technologies, from the private equity firm KKR for $5.5 billion. The deal follows others ...

Swiss drugs firm says acquisition will transform it into an end-to-end provider of APIs and delivery systems Swiss pharma giant Lonza is buying drug capsule and delivery systems firm Capsugel from its ...

(Reuters) - Swiss pharmaceutical supplier Lonza Group AG (LONN.S) on Thursday announced a deal to buy Capsugel, a U.S. maker of capsules and other drug delivery systems, from KKR & Co LP (KKR.N) for ...

(Reuters) — Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR & Co LP to acquire Capsugel, a U.S. maker of capsule products and ...

Here are four things to know about the deal. 1. Capsugel, based in Morristown, N.J., manufactures empty drug capsules, along with several other drug delivery systems. 3. Lonza’s shares fell by more ...

Swiss pharmaceutical manufacturer Lonza Group is in advanced talks to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems, for more than $5 billion, according to people ...